Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01010828
Other study ID # JP12
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2009
Est. completion date March 31, 2012

Study information

Verified date March 2019
Source Zimmer Biomet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will show whether Tri-Vector method can ensure more extensive visual field and conduct the precise surgery when compared with Mini Mid-Vastus method by conducting 2 types of skin incision approach, Tri-Vector for 36 patients or Mini-Mid Vastus for 36 patients in Vanguard PS artificial knee joint total replacement observational period before and during surgery.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date March 31, 2012
Est. primary completion date March 31, 2012
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- The patients who need artificial knee joint replacement in ordinary medical consultation are selected as the subjects.

Exclusion Criteria:

- Patients with infections such as osteomyelitis, or sepsis (Because the affected part is lesioned, excellent surgical results cannot be obtained.)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Incision technique
Tri-Vector Approach retains the majority of 3 vectors of quadriceps.
Incision technique
Mini Mid-Vastus Approach

Locations

Country Name City State
Japan National Hospital Organization, Osaka National Hospital Osaka

Sponsors (2)

Lead Sponsor Collaborator
Zimmer Biomet Biomet Japan, Inc.

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Force from femoral and tibial side to retract and bring visual field into view intraoperatively
Secondary Incision length intraoperatively
Secondary Visual determination of the extension and flexion gap intraoperatively